VALERITAS HOLDINGS INC. VLRX Cash Flow

Valeritas holdings inc. (VLRX)

CashFlow / Quarterly

Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15
Operating activities
Net loss
-13,244	-14,019	-14,684	-11,864	-11,531	-10,960	-11,574	-14,935	-10,578	-11,982	-11,806	-9,846	-9,157	-10,466	-16,898	-12,033	-14,494	-40,647	-20
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of property and equipment
332	300	300	299	305	360	300	484	472	472	472	829	378	413	421	-	-	-	-
Amortization of financing costs
6	7	6	6	6	5	4	4	4	-1	13	6	7	406	3,983	-	-	-	-
Noncash interest expense
395	376	1,100	1,091	1,064	1,020	987	974	955	938	1,571	1,554	1,589	2,016	2,601	-	-	-	-
Share-based compensation expense
699	813	1,069	997	1,020	1,011	1,029	1,002	1,565	1,587	1,429	427	862	1,942	561	-	-	-	-
Obsolete inventory reserve
-54	406	230	-	-196	109	87	-	-	-111	111	-	-	-	0	-	-	-	-
Change in fair value of derivative liabilities
-	-	-	-	-	-	-	1	54	-32	198	113	-27	-42	-593	-	-	-	-
Deferred revenue reduction
-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-
Sales return provision
-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-
Sales return provision
114	-93	-82	-	56	141	17	-	0	0	0	-	-	-	-	-	-	-	-
Accrued restructuring cost
-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,331	-	-	-	-
Changes in:
Accounts receivable
774	-74	-574	694	739	837	33	146	564	-338	157	287	-415	274	328	-	-	-	-
Other receivables
-	-	-	-	-	-	-	-	-	-	276	47	-87	71	-351	-	-	-	-
Accounts payable, related party
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	15
Interest payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Inventories
-1	1,236	1,185	117	-528	-1,003	133	-265	252	-268	-998	-735	-1,015	-563	913	293	-360	1,262	0
Deferred cost of goods sold
-	-	-	-	-	-	-	66	-309	40	52	-177	105	8	-109	-	-	-	-
Prepaid expense and other current assets
-107	682	-413	-179	-35	410	128	-166	63	452	-284	-255	-31	282	-162	-	-	-	-
Other assets
-3	277	-126	94	-5	166	9	-102	-12	109	0	-	-	-	-	-	-	-	-
Amortization of debt discount
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2
Accounts payable
393	-410	234	1,470	-1,014	-91	-1,382	687	881	-1,022	507	1,707	-1,189	-1,509	-1,837	-212	1,468	2,097	-10
Accrued expense
1,917	1,652	547	-262	2,045	773	-607	-344	117	1,456	-950	-875	899	329	-777	-	-	-	-
Deferred revenue
-	-	-	-	-	-	-	-	-	54	161	-345	240	-6	-161	-	-	-	-
Deferred rent liability
0	0	0	0	12	10	29	53	-25	-21	-19	-20	-17	56	-92	-	-	-	-
Net cash provided by financing activities
-	-	-	-	-	-	-	-	-	-522	49,273	0	0	24,120	12,657	-	-	-	-
Net increase (decrease) in cash and cash equivalents
-	-	-	-	-	-	-	-	-8,176	-8,923	41,318	-5,663	-4,918	16,038	1,620	-	-	-	-
Net cash used in operating activities
-10,257	-12,894	-11,179	-8,936	-8,517	-8,324	-11,413	-	-	-	-	-	-	-	-	-	-	-	-13
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-8,336	-7,978	-5,674	-5,039	-8,054	-10,894	-	-	-	-
Investing activities
Proceeds from sales of property and equipment
-	-	-	-	-	-	-	67	33	19	66	13	121	0	0	-	-	-	-
Acquisition of property and equipment
383	422	604	386	353	615	198	511	239	84	43	2	0	28	143	-	-	-	-
Net cash used in investing activities
-383	-422	-604	-386	-353	-615	-198	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in investing activities
-	-	-	-	-	-	-	-	-	-65	23	11	121	-28	-143	-	-	-	-
Financing activities
Repayment of finance lease
31	30	29	46	5	26	20	0	0	0	0	0	0	0	26	-	-	-	-
Proceeds from issuance of common stock and exercise of warrants, net of fees
6,580	3,866	793	29,745	7	27,542	0	0	6	-522	49,308	0	0	23,964	0	-	-	-	-
Proceeds from issuance of common stock through ESPP
0	0	0	-	99	0	137	-	0	0	0	-	-	-	-	-	-	-	-
Proceeds from issuance of Series AB ($5,819 received from related party CRG in 2016)
-	-	-	-	-	-	-	-	-	-	-	0	0	0	5,819	-	-	-	-
Proceeds from exercise of warrants by a related party
-	-	-	-	-	-	-	-	-	-	-	0	0	349	7,026	-	-	-	-
Costs associated with investor capital contributions
-	-	-	-	-	-	-	-	-	-	-	-	-	-	162	-	-	-	-
Costs associated with debt restructuring
-	-	-	-	-	-	-	0	0	0	35	0	0	355	0	-	-	-	-
Repayment to loan payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Proceeds from loan payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5
Net cash provided by financing activities
6,549	3,836	764	32,805	101	27,516	117	-	-	-	-	-	-	-	-	-	-	-	5
Net decrease in cash and cash equivalents
-4,091	-9,480	-11,019	-	-8,769	18,577	-11,494	-	-	-	-	-	-	-	-	-	-	-	-
Increase (decrease) in cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-8
Supplemental disclosures of cash flow information
Right-of-use assets
0	1,026	1,566	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred rent
0	0	109	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on sale of property and equipment
-	-	-	-	-	-	-	-18	108	19	66	13	121	0	0	-	-	-	-
Deferred revenue reduction
0	0	0	0	0	0	1,638	-	-	-	-	-	-	-	-	-	-	-	-
Deferred cost of goods sold reduction
0	0	0	0	0	0	539	0	0	0	0	-	-	-	-	-	-	-	-
Accrued distribution fees and managed care costs
0	0	0	0	0	0	343	0	0	0	0	-	-	-	-	-	-	-	-
Noncash investing and financing
Capital lease obligation
0	0	0	45	0	0	315	0	0	0	0	-	-	-	-	-	-	-	-
Accrued/payable offering costs
103	0	0	-	-214	203	95	-	0	-516	516	-	-	-	-	-	-	-	-
Accrued offering costs/acquisition related costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	91	-	-	-	-
Write off of debt issuance costs
-	-	-	-	-	-	-	0	0	0	107	0	0	0	0	-	-	-	-
Related party conversion of debt to Series A preferred stock
-	-	-	-	-	-	-	0	0	0	27,500	0	0	0	0	-	-	-	-
Property and equipment additions included in accounts payable
-97	-162	352	-	0	0	0	-	-	-	-	-	-	-	24	-	-	-	-